Work

35-OR: Risk of Cardiovascular Outcomes in Diabetes Patients following the Addition of SGLT2 Inhibitors vs. Sulfonylureas to Baseline GLP-1RA Therapy

FWCI: 0.378
Cites:
Cited by: 2
Related to: 10